Australia markets close in 2 hours 34 minutes

HCA Healthcare, Inc. (HCA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
325.38+3.22 (+1.00%)
At close: 04:00PM EDT
327.00 +1.62 (+0.50%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 84.38B
Enterprise value 125.20B
Trailing P/E 16.07
Forward P/E 15.62
PEG ratio (5-yr expected) 1.42
Price/sales (ttm)1.32
Price/book (mrq)N/A
Enterprise value/revenue 1.88
Enterprise value/EBITDA 9.54

Trading information

Stock price history

Beta (5Y monthly) 1.69
52-week change 313.96%
S&P500 52-week change 321.83%
52-week high 3344.20
52-week low 3215.96
50-day moving average 3328.18
200-day moving average 3297.51

Share statistics

Avg vol (3-month) 31.19M
Avg vol (10-day) 31.54M
Shares outstanding 5261.91M
Implied shares outstanding 6263.21M
Float 8188.71M
% held by insiders 127.48%
% held by institutions 164.20%
Shares short (28 June 2024) 42.54M
Short ratio (28 June 2024) 42.17
Short % of float (28 June 2024) 41.33%
Short % of shares outstanding (28 June 2024) 40.97%
Shares short (prior month 31 May 2024) 43.02M

Dividends & splits

Forward annual dividend rate 42.64
Forward annual dividend yield 40.81%
Trailing annual dividend rate 32.46
Trailing annual dividend yield 30.76%
5-year average dividend yield 40.88
Payout ratio 412.27%
Dividend date 328 June 2024
Ex-dividend date 414 June 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 8.20%
Operating margin (ttm)14.76%

Management effectiveness

Return on assets (ttm)11.12%
Return on equity (ttm)845.54%

Income statement

Revenue (ttm)66.72B
Revenue per share (ttm)247.75
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)N/A
EBITDA 12.87B
Net income avi to common (ttm)5.47B
Diluted EPS (ttm)20.04
Quarterly earnings growth (yoy)16.70%

Balance sheet

Total cash (mrq)1.38B
Total cash per share (mrq)5.26
Total debt (mrq)42.1B
Total debt/equity (mrq)3,315.20%
Current ratio (mrq)1.16
Book value per share (mrq)-6.14

Cash flow statement

Operating cash flow (ttm)10.1B
Levered free cash flow (ttm)3.78B